Not Signed In - ActivBiotics Announces Initiation Of Phase II Study In Carotid Atherosclerosis
Thu, 15 Feb 2007 08:00 AM EST
... ActivBiotics, Inc. announced today that patient enrollment has begun in a Phase II study examining the effect of rifalazil, a potent anti-chlamydial antibiotic, on atherosclerotic changes in the carotid artery. [click link for full article] ...
Related Topics
- Atherosclerosis
- Arteriosclerosis/Atherosclerosis
- Clinical Trials
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Carotid Artery
- Carotid Artery Disease
- Kniest dysplasia
- Radiation Studies
- Angioplasty
- Juvenile Diabetes
- Phenylephrine and Guaifenesin Capsules
- Pena Shokeir II Syndrome
- Cockayne Syndrome Type II
- Ramsay Hunt Syndrome Type II
- Pseudoephedrine and Guaifenesin ER
- Collagenopathy, types II and XI
- PET Study
- Caregiving
email this page
print this page
bookmark this page
feedback on this page
